Natera Officer Sells $905K in Shares for Tax Withholding
Natera, Inc.
Subscribe to track NTRA
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
🚨 INSIDER TRANSACTION ALERT: NTRA
Company: Natera, Inc.
Insider: Solomon Moshkevich (President, Clinical Diagnostics)
Type: Sale (Sell-to-Cover / 10b5-1)
Shares: 2,172
Price: ~$416.88 (Weighted Avg)
Total Value: $905,467.54
Remaining Holdings: 104,742 shares
Filing Date: 2026-10-30
Comprehensive Analysis
Executive Summary
On October 27 and October 28, 2026, Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc. ($NTRA), sold an aggregate of 2,172 shares of common stock for a total consideration of approximately $905,468. Following these transactions, Mr. Moshkevich directly holds 104,742 shares of Natera common stock.
Transaction Breakdown
- October 27, 2026: Sold 1,010 shares at $406.00 per share ($410,060.00).
- October 28, 2026: Sold 1,162 shares at an average price of $426.3404 per share ($495,407.54).
- Total Disposed: 2,172 shares across both dates.
Context & Trading Significance
This disposition carries Low trading significance. As detailed in the filing's footnotes, the sales were automatic sell-to-cover transactions effected to satisfy tax withholding and remittance obligations arising from the vesting of Restricted Stock Units (RSUs). These transactions were executed under pre-established written instructions intended to qualify for the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.